Position history for D. E. Shaw & Co., Inc.'s holdings in XERIS BIOPHARMA HOLDINGS INC
D. E. Shaw & Co., Inc. holds 7.8M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), worth $45.2M as of 2026-Q1. The position was increased (+2.8% shares). XERS represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.
Current Value
$45.2M
Current Shares
7.8M
Total Value Change
+$44M
Total Shares Change
+7.3M
Other major holders of XERS: BlackRock, Inc., VANGUARD GROUP INC
Increased |
| 7.8M |
+2.8% |
| $45.2M |
| 0.0% |
| $5.94 |
30 |
| 2025-Q4 | Increased | 7.6M | +29.7% | $59.5M | 0.0% | $7.31 | 37 |
| 2025-Q3 | Increased | 5.8M | +52.3% | $47.5M | 0.0% | $8.08 | 41 |
| 2025-Q2 | Increased | 3.8M | +25.6% | $17.9M | 0.0% | $4.70 | 35 |
| 2025-Q1 | Increased | 3.1M | +123.9% | $16.8M | 0.0% | $5.58 | 46 |
| 2024-Q4 | Increased | 1.4M | +38.4% | $4.6M | 0.0% | $3.38 | 35 |
| 2024-Q3 | Increased | 985,015 | +90.2% | $2.8M | 0.0% | $2.87 | 41 |
| 2024-Q2 | Decreased | 518,024 | -26.7% | $1.2M | 0.0% | $2.25 | 0 |